Questcor Pharmacueticals, Inc. (QCOR) Tops Q4 EPS by 5c

Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) reported Q4 EPS of $0.47, $0.05 better than the analyst estimate of $0.42. Revenue for the quarter came in at $75.5 million versus the consensus estimate of $72.77 million.

For earnings history and earnings-related data on Questcor Pharmacueticals, Inc. (QCOR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Netflix climbs following Ackman stake, up 1.8%
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• Kolibri Global Energy Inc. (KGEI) Misses Q2 EPS by 2c